We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $842K | Put options by funds: $211K

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

6% less funds holding

Funds holding: 137 → 129 (-8)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

36% less capital invested

Capital invested by funds: $522M → $332M (-$190M)

Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
38
Reduced
41
Closed
35
Calls
$842K
Puts
$211K
Net Calls
+$631K
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$24.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19M
3
DM
Deerfield Management
New York
+$18M
4
Millennium Management
Millennium Management
New York
+$9.31M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11.4M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$11.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
4
ClearBridge Investments
ClearBridge Investments
New York
-$9.93M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$3.2M +$4.77M +456,027 New
Renaissance Technologies
27
Renaissance Technologies
New York
$2.7M +$655K +62,600 +19%
N
28
Nuveen
North Carolina
$2.67M +$67.1K +6,410 +2%
Walleye Capital
29
Walleye Capital
New York
$2.64M +$1.08M +103,259 +38%
Voloridge Investment Management
30
Voloridge Investment Management
Florida
$2.37M +$2.68M +256,005 +317%
Charles Schwab
31
Charles Schwab
California
$2.28M +$289K +27,597 +9%
NAM
32
Nexpoint Asset Management
Texas
$2.17M – – –
Deutsche Bank
33
Deutsche Bank
Germany
$2.15M -$2.76M -263,664 -46%
DCM
34
DAFNA Capital Management
California
$2.03M – – –
AGA
35
Altrinsic Global Advisors
Connecticut
$1.9M – – –
JAMONY
36
Jacob Asset Management of New York
California
$1.72M +$539K +51,517 +27%
Goldman Sachs
37
Goldman Sachs
New York
$1.59M +$128K +12,255 +6%
Wellington Management Group
38
Wellington Management Group
Massachusetts
$1.46M +$2.17M +207,269 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.4M -$3.53K -337 -0.2%
DA
40
DCF Advisers
Connecticut
$1.35M +$581K +55,564 +41%
EWM
41
Endurance Wealth Management
Rhode Island
$1.11M -$491K -46,901 -23%
CS
42
Candriam SCA
Luxembourg
$1.06M +$1.58M +151,000 New
HF
43
HRT Financial
New York
$1.05M +$1.56M +149,455 New
AA
44
AlphaCentric Advisors
Puerto Rico
$962K +$936K +89,500 +188%
Stifel Financial
45
Stifel Financial
Missouri
$913K +$293K +27,984 +27%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$795K -$11.6K -1,105 -1%
SG Americas Securities
47
SG Americas Securities
New York
$789K -$281K -26,893 -19%
Allianz Asset Management
48
Allianz Asset Management
Germany
$764K -$287K -27,400 -20%
PPA
49
Parametric Portfolio Associates
Washington
$704K -$195K -18,651 -16%
Swiss National Bank
50
Swiss National Bank
Switzerland
$688K – – –
1
2
3 4 5

AERI Hedge Fund Activity: Q4 2021 in Review

129 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2021, worth a combined $332M — down 36% from $522M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of AERI and 28 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Jefferies Group, opening a new position worth an estimated $24.9M. The largest seller was PFM Health Sciences, cutting an estimated $11.4M.

  • 129 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2021, down from 137 in Q3 2021.
  • Funds reported $332M of Aerie Pharmaceuticals stock for Q4 2021, down 36% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q4 2021 and 35 closed out, a net change of -7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2021 was Jefferies Group, an estimated $24.9M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2021 was PFM Health Sciences, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.